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Abstract: Background: Yttria-stabilized zirconia nanoparticles can be applied as fillers to improve
the mechanical and antibacterial properties of luting cement. The aim of this study was to synthesize
yttria-stabilized zirconia nanoparticles by the sol–gel method and to investigate their composition,
structure, morphology and biological properties. Methods: Nanopowders of ZrO2 7 wt% Y2O3
(nY-ZrO) were synthesized by the sol–gel method and were sintered at three different tempera-
tures: 800, 1000 and 1200 ◦C, and their composition, size and morphology were investigated. The
biocompatibility was investigated with human gingival fibroblasts (hGFs), while reactive oxygen
species (ROS) production was evaluated through fluorescence analysis. Results: All synthesized
materials were composed of tetragonal zirconia, while nanopowders sintered at 800 ◦C and 1000 ◦C
additionally contained 5 and 20 wt% of the cubic phase. By increasing the calcination temperature,
the crystalline size of the nanoparticles increased from 12.1 nm for nY-ZrO800 to 47.2 nm for nY-
ZrO1200. Nano-sized particles with good dispersion and low agglomeration were received. Cell
culture studies with human gingival fibroblasts verified the nanopowders’ biocompatibility and their
ROS scavenging activity. Conclusions: the obtained sol–gel derived nanopowders showed suitable
properties to be potentially used as nanofillers for dental luting cement.
Keywords: nanoparticle; chemical precipitation; yttrium; zirconium; gingival fibroblasts; toxicity
tests; oxidative stress
1. Introduction
Various nanoparticles have been proposed for the reinforcement of different dental
materials such as restorative composite materials, glass ionomer cement, dental adhesives
and calcium silicate cement. Among them, silica, alumina, glass and metal oxide nanoparti-
cles led to improved commercial products with enhanced mechanical properties. In the last
two decades, high purity zirconia (ZrO2) nanomaterials gained significant interest in dental
technology, as they combine high toughness, high strength and high corrosion resistance
with biocompatibility, lack of toxicity and antibacterial properties [1]. Although their pri-
mary application is in the fabrication of dense polycrystalline zirconia ceramics in the form
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of dental crowns, fixed partial dentures, implants, implant abutments, posts, orthodon-
tic brackets, etc. [2,3], they have also been proposed as nano-filling materials [4,5] and
nanocoatings [6,7], while due to their opaque white nature, they can also serve as radiopac-
ity elements in cement [8] and root filling materials [9]. Zirconia filler nanoclusters with
particle sizes ranging from 20 to 75 nm were used for strengthening commercial restorative
dental composites such as Filtek Z250 and Harvard ZirkonCore [4]. The incorporation of
ZrO2 nanoparticles in various matrices can result in composite materials with significantly
improved flexural strength, fracture toughness and shear bond strength [10,11]. Due to
their antibacterial properties, they could also be applied as fillers in various dental care
materials such as toothpaste, lining materials and dental cement [12,13]. The reinforcement
of resin luting cement by ZrO2-based nanofillers could be beneficial for the establishment
of durable bonds with zirconia fixed restorations.
Zirconium oxide presents with three temperature-dependent crystal phases: mon-
oclinic (m-ZrO2) is thermodynamically stable at room temperature and up to 1100 ◦C,
tetragonal (t-ZrO2) between 1100 and 2370 ◦C and cubic (c-ZrO2), which is found at a
higher temperature above 2370 ◦C [14,15]. Tetragonal zirconia presents with the most
favorable mechanical properties due to the phenomenon of toughening transformation,
i.e., its transformation under moisture and stress to the thermodynamically stable at room
temperature monoclinic phase [16]. During the cooling of the material at 950 ◦C, conversion
from the tetragonal to the monoclinic (t→m) form takes place [17]. This phase transfor-
mation is accompanied by a volume increase of ~4% [18]. A different transformation
(c→t) can cause the creation of a different tetragonal phase (t’), which is rich in yttrium
with a smaller crystal size and higher resistance to the t→m phase transformation [19]. In
order to stabilize tetragonal zirconia at room temperature, various doping elements were
tested, such as cerium, yttrium, calcium, magnesium, etc., and yttrium is the most utilized.
Yttrium stabilized tetragonal zirconia (YSZ) has attracted worldwide interest as it presents
high strength and toughness [20].
Various methods were proposed for the synthesis of zirconia nanopowder [21]. The
most effective ones are wet-chemical synthesis approaches, such as sol–gel, co-precipitation
and hydrothermal routes [22–25]. Using sol–gel synthesis, uniform, nano-sized powders
with high purity can be produced [26]. This process is based on the hydrolysis and
subsequent condensation reactions of inorganic salts and metal–organic compounds. These
reactions lead to the formation of a sol which is converted into a gel. The gel is further
processed with calcination at various temperatures to obtain a homogenous nanopowder.
In the co-precipitation method, an aqueous solution is prepared where zirconia precursors
are diluted, and then a chemical precipitant agent is added for the effective precipitation
of metal hydroxides. The precipitated powder is subsequently rinsed, filtered and dried
before calcination at various temperatures to receive the desired crystalline phases. The
nucleation and growth mechanisms can be monitored by modifying the solution’s pH and
temperature. It is an effective and low-cost method, although it generally results in a wide
particle size distribution and agglomeration [27]. Hydrothermal routes usually involve
water as the solvent and an initial co-precipitation at high temperatures and pressure
in sealed containers to obtain a crystalline powder. It is also a low-cost and ecological
method resulting in homogenous products, although presenting similar drawbacks of
co-precipitation such as high agglomeration, which results in poor sinterability [28,29].
All of these methods necessitate precise control of all the involved parameters (pH, time,
temperature, etc.) to receive the desired size and crystalline nature of nanoparticles.
Nanoparticles with an average size below 50 nm were suggested as appropriate zirconia
nanofillers in dental restorative composites and cement [13,30].
Despite the fact that pure monoclinic zirconia nanoparticles have been used as fillers in
many dental materials [7], YSZ nanoparticles with tetragonal structure at room temperature
have only scarcely been evaluated [31,32], although they may show higher enhancement
of the mechanical properties of dental composites and cement. The aim of this study
was to synthesize yttria-stabilized zirconia (YSZ) nanopowders, to be used as nanofillers
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in dental cement by the sol–gel method and to investigate the impact of different sinter-
ing temperatures on their crystal structure, morphology and biocompatibility. The null
hypothesis was that sintering temperature would not affect the biocompatibility of the
synthesized materials.
2. Materials and Methods
2.1. Synthesis of Nanoparticles
ZrO2 7 wt% Y2O3 nanoparticles were synthesized by the sol–gel method using zirco-
nium oxychloride octahydrate (ZrOCl2 8H2O) and yttrium nitrate hexahydrate (Y(NO3)3
6H2O) as starting materials [33,34]. Raw materials were dissolved in double distilled
water, mixed and then an aqueous solution of ethylene glycol and an aqueous citric acid
concentrate was added under heating and stirring. The molar ratios of citric acid:metal
and citric acid:ethylene glycol were 3.65 and 1, respectively. The materials were heated
stepwise to the temperatures of 100 ◦C, 200 ◦C and 300 ◦C for 3 h/each to eliminate organic
materials [33]. The obtained gel was sintered at three different temperatures: 800, 1000 and
1200 ◦C for 2 hours after differential thermal and thermogravimetric analyses (DTA/TG).
The obtained calcinated materials were ground in a mortar into fine powders (nY-ZrO800,
nY-ZrO1000, nY-ZrO1200).
2.2. Differential Thermal and Thermogravimetric Analysis (TG-DSC)
The thermal behavior of the dried gel was investigated by Thermogravimetric Anal-
ysis and Differential Scanning Calorimetry (TG-DSC) performed in dry air from room
temperature up to 1300 ◦C, with a heating rate of 10 ◦C min−1 (SETSYS 16/18, SETARAM,
Lyon, France). The sample (≈35 mg) was placed in alumina crucibles while an empty
alumina crucible was used as a reference.
2.3. Fourier Transform Infrared Analysis (FTIR)
The FTIR transmittance spectra of the nanoparticles sintering were obtained by the
KBr technique. A Spectrometer (Spectrum 1000, PerkinElmer, Inc., Waltham, MA, USA)
was employed measuring in the MIR region (4000–400 cm−1) with a resolution of 4 cm−1
and performing 32 scans per spectrum.
2.4. X-Ray Diffraction Analysis (XRD)
The XRD analysis of the nanoparticles was performed using a diffractometer (Rigaku
Ultima, Rigaku, Japan) with Ni-filtered CuKa radiation (λ = 0.1542 Å). A 2θ range of 5–90◦
was measured, with a scanning speed of 0.05 ◦ 2θ/s, 1.5 s per step. The ICDD PDF-4+ (2009)
database was used for the identification of the phases contained in the studied samples.
The crystallite size was calculated with the Scherer’s formula: D = 0.89λ/β cosθ, where D
is the crystallite size (nm), λ is the wavelength of X-ray beam (nm), β is the full width at
the half maximum of the main peak, and θ is the diffraction angle (◦). Rietveld analysis of
XRD patterns was performed to quantify the crystalline phase contents.
2.5. Scanning Electron Microscopy-Energy-Dispersive X-ray Spectroscopy (SEM/EDX)
The morphology of all samples was determined by Scanning Electron Microscopy
SEM (Auriga Base, Carl-Zeiss) associated with an energy dispersive X-ray (EDX) analyzer
(X-MaxN, Oxford Instruments, Abingdon, UK) to detect their chemical composition during
SEM observation.
2.6. Transmission Electron Microscopy (TEM)
For TEM imaging, the NPs samples were dispersed in ethanol and placed in an
ultrasonic bath for 10 min. Then, a drop of the suspension was placed onto a Lacey
Carbon Film (Agar Scientific Ltd., Stansted, UK). For imaging and morphology analysis of
nanoparticles, a latest-generation Field Emission Gun Transmission Electron Microscope
(Talos F200X) was utilized. The mean particle size of the samples was determined by
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measuring the size of 50 particles. The exact distance from the central spot and each one of
the diffracted spots was measured in program Image J. Experimental interplanar spacing
(d) was estimated from the formula: dspacing = λL/R [35,36].
2.7. Dynamic Light Scattering Analysis (DLS)
Dynamic light scattering (Zetasizer Nano ZS) was used for the estimation of hydro-
dynamic size and polydispersity index (PDI) of the nanoparticles. Measurements were
performed at 25 ◦C after 5 min sonication of the samples that contained the different
nanoparticles dispersed in distilled water at a concentration of 1 g/L.
2.8. Establishment of Primary Cell Cultures
Human gingival fibroblasts were grown in primary culture from free gingiva biopsies
received from young, healthy donors after extraction of their third molars. The Institu-
tional Ethical Committee approved the protocol (#35/07-05-2018), and volunteer patients
signed their informed consent forms before extractions. In brief, gingival tissue biopsies
were placed in 25 cm2 culture flasks with Dulbecco modified Eagle medium (DMEM,
Invitrogen) supplemented with 10% Fetal Bovine Serum (FBS, Invitrogen) and penicillin
(100 units/mL), streptomycin (100 mg/mL) and Amphotericin B (0.25 mg/mL) to allow
the outgrowth of cells. The flasks were incubated at 37 ◦C in a humidified atmosphere
with 5% CO2, and the medium was replaced twice a week. When the primary cell culture
reached confluence (70–80% of the flask), cells were detached with trypsin, transferred to a
larger 75 cm2 flask (passage 1) and then subcultured for further experiments. Cells from
the 5th and 6th passages were used for all experiments.
2.9. Evaluation of Cell Viability by the MTT Assay
Mitochondrial activity evaluation of human gingival fibroblasts with nY-ZrO was
performed using the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide). Cells were seeded in 96 well-plates (3 × 104 cells/well) and left 24 h to attach in
a 5% CO2 incubator at 37 ◦C. A stock solution of 2 mg of NPs per 1mL of culture medium
was prepared, and a series of dilutions with nanoparticles at different concentrations (0.1,
0.25 and 0.5 mg/mL) were evaluated after 24 and 72 h of incubation. Those concentrations
were selected based on previous studies on the toxicity of various nanoparticles [37–39].
Untreated cells served as a positive control, while cells cultured with a culture medium
without fetal bovine serum served as a negative control. The proliferation of the cells was
calculated by measuring the mitochondrial dehydrogenase activity of living cells, which
was verified by the transformation of the yellow tetrazolium salt into blue formazan crystals
by using dimethyl-sulfoxide (DMSO) (Sigma Aldrich, St. Louis, MO, USA) as dissolvent.
Optical density was determined spectrophotometrically by a microplate reader (Epock,
Biotek, Biotek Instruments, Inc, Winooski, VT, USA). Measurements were performed at
a wavelength of 545 nm with a reference filter at 630 nm. Experiments were performed
in triplicates. The results were expressed as % percentage of the control average optical
density value.
2.10. Fluorescence Analysis for the Detection of ROS Levels
The cell-permeable ROS-sensitive probe 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCFDA) was used for the detection of reactive oxygen species [40], which fluoresces at
520 nm (λex480 nm) upon oxidation. A stock solution of 0.5 mM H2DCFDA in DMSO was
prepared. In order to avoid autofluorescence, controls were prepared without H2DCFDA
but only with its solvent, DMSO. The probe was added to the well plates of human gingival
fibroblasts treated at different concentrations of yttria-stabilized zirconia nanofillers for 24
and 72 h and left to incubate for 30 min (oxidation). Measurement of the fluorescence was
performed after transferring the desired suspensions in 96-well black microplates using a
SAFAS Xenius fluorometer. The relative fluorescence is expressed as “% maximal emission”
as determined with the software “Xenius”.
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2.11. Statistical Analysis
Statistical analysis of the cell viability and ROS levels data was performed with the
Paired Samples t-Test using the SPSS software. The level of statistical significance was set
at 0.05 (p < 0.05).
3. Results
3.1. TG-DSC Analysis
The mass loss along with its first derivative (dTG) and the heat flow curves of the
prepared gel is presented in Figure 1.
Figure 1. TG, dTG and Heat Flow curves of the gel at 10 ◦C/min heating rate in dry air.
From the dTG curve, it can be concluded that the overall weight loss (85.3%) occurred
in five main stages. The first step took place at temperatures between 26 and 150 ◦C,
accompanied by an endothermic peak at ~100 ◦C, and is attributed to the evaporation of
the absorbed water (3.5% mass loss) [33,34,41,42]. In the temperature range of 150–240 ◦C,
the second step of the degradation presented an endothermic peak at ~210 ◦C that can be
ascribed to the release of nitrates and/or the citrate matrix’s decomposition (45% mass
loss) [43,44]. The third stage of the gel’s degradation occurred around 240–300 ◦C with an
endothermic peak appearing at ~286 ◦C, possibly due to the decomposition of zirconyl
oxalate (ZrOC2O4) and Y2(C2O4)3 (20.9% mass loss) [43,45]. An exothermic peak at ~355 ◦C
took place on the fourth step of the process, which took place at temperatures between 300
and 540 ◦C. This peak could be attributed to the degradation of organic and organometallic
compounds, CO2 removal and the destruction of the polymeric network [34] or to the
oxidation of the residual organic compounds [44] (mass loss 15.9%). During the final step
of the degradation that occurred in the temperature range of 540–900 ◦C, an exothermic
peak appeared at ~628 ◦C, possibly related to the removal of the element carbon from the
final compound [44] and/or a crystalline–amorphous phase transition [33,45].
3.2. FTIR Analysis
Infrared vibrational spectra of Y-Zr powders, sintered at temperatures 800, 1000 and
1200 ◦C, are presented in Figure 2. FTIR transmission spectra of all the specimens showed
broad bands at about 430–440 cm−1 and a weak broad band at around 600–650cm−1
characteristic for the tetragonal phase [46]. Apparently, no monoclinic phase was detected
in none of the specimens because of the absence of the distinctive sharp band for this phase
at 740cm−1. Low-intensity peaks at 1400 and 1650 cm−1 of nY-ZrO800 specimen might
be attributed to the symmetric and asymmetric stretching vibrations of the carboxylate
groups of organic components of decomposed gel [34].
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Figure 2. (a) FTIR; (b) XRD analysis of the zirconia nanoparticles sintered at 800, 1000 and 1200 ◦C, respectively. Higher
magnification of XRD patterns in the area of 72–76 2θ is presented in (c) to unravel the splitting of the peaks due to the
presence of the tetragonal phase.
3.3. XRD Analysis
The XRD patterns of the three experimental materials are displayed in Figure 2, while
the percentages of crystalline phases are presented in Table 1. The diffraction peaks of
all nY-ZrO1200 specimen show the formation of pure tetragonal zirconium yttrium oxide
Zr0.9Y0.101.95 without any detectable secondary phases. The distinguishing characteristic
peaks for tetragonal zirconia phase occur at 2θ = 30 to 45 for the (111), (002), (200), (202)
and (112); at 2θ = 45 to 65 for the (202), (220), (113), (311) and (222); and at 2θ = 72 to 85
for (004), (400), (331), (313), (420) and (402) reflections [47,48]. It is important to mention
that the double peak around 73.2 and 74 2θ angles are characteristic for tetragonal zirconia
crystal [48,49]. Specimens nY-ZrO1000 and nY-ZrO800 also contain ~5% and ~20% of cubic
zirconium yttrium oxide, respectively. By increasing the sintering temperature from 800
to 1000 and 1200 ◦C, the peaks appeared sharper and more intense. At the same time, the
full width at half maximum (FWHM) of diffraction pattern became narrower, indicating
increased crystallinity of the specimens. Thus, the crystallite size of YSZ nanoparticles
calculated by the Sherrer equation was 12.1nm for nY-ZrO800, 29.2nm for nY-ZrO1000
powder and 47.2nm for nY-ZrO1200.






SEM analysis (Figure 3) in high magnifications (100,000×) showed the fine submicron-
sized (~10–15 nm) particles with uniform spherical morphology in nY-ZrO800 speci-
mens. With the increase in sintering temperature to 1000 ◦C, grains become bigger in
size (30–50 nm) and have a low agglomerated microstructure. Finally, specimens sintered
at 1200 ◦C seem more agglomerated and have polyhedral morphology with particle sizes
of more than 100 nm. EDX analysis of three specimens detected Zr, Y and minor traces of
Hf, with a Y/Zr ratio around 0.06–0.07.
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Figure 3. SEM images of the nY-ZrO powders sintered at 800 ((a)-nY-ZrO800), 1000 ((b)-nY-ZrO1000) and 1200 ◦C ((c)-nY-
ZrO1200), showing increase in crystalline size with increase in sintering temperature.
3.5. TEM
The obtained TEM image of nY-ZrO powders sintered at 1000 ◦C is shown in Figure 4a.
The observed nanoparticles are uniform, homogeneously distributed and well defined.
Their morphology is polyhedral, and their size ranges between 9 and 53 nm, with an
average calculated particle size of 28.4 nm (±11 nm). In images with higher resolu-
tion (Figure 4b), crystal lattice could be observed, while dark inclusions indicate well-
crystallized grains. The electron pattern of crystals corresponds to pure tetragonal zirconia,
which can be estimated from calculations of interplanar spacings. (Table 2).
Figure 4. TEM image showing morphology of nanoparticles sintered at 1000 ◦C (a–c), and electron
diffraction pattern (d).
Table 2. Experimental and theoretical d-value (interplanar spacing) of the phase identified as tetrago-
nal Zirconia (Identification Card Number# 82-1241).





Ring 1 6.5 3.250 2.892 2.963 0.0239 2.3924 101
Ring 2 7.6 3.800 2.474 2.559 0.0332 3.3151 110
Ring 3 10.3 5.150 1.825 1.818 0.0043 0.4260 112
Ring 4 12.45 6.225 1.510 1.544 0.0221 2.2058 103
Ring 5 13 6.500 1.446 1.482 0.0239 2.3924 202
Ring 6 15.65 7.825 1.201 1.212 0.0085 0.8503 104
Ring 7 17.35 8.675 1.084 1.144 0.0530 5.2986 310
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3.6. DLS
The average size of all synthesized powders, analyzed by Dynamic Light Scattering
techniques (DLS), were estimated 243.9 nm for nY-ZrO800, 188.96 for nY-ZrO1000 and
364.00 for nY-ZrO1200 (Table 3). The low polydispersity index, especially in the nY-ZrO
800 and nY-ZrO1000 samples (<0.28), indicates narrow size distribution of grains and good
quality of the obtained materials.
Table 3. Results from DLS analysis.
Specimen Size (d.nm) StandardDeviation %Std Deviation Pdl
nY-ZrO800 243.890 2.345 0.961 0.265
nY-ZrO1000 188.956 5.831 3.086 0.277
nY-ZrO1200 364.003 8.216 2.257 0.376
3.7. Evaluation of Cell Viability
MTT assay of the tested specimens (Figure 5) showed that nY-ZrO1000 and nY-
ZrO1200 presented a biocompatible biological behavior as compared to the positive control
in 24 and 72 h (p < 0.001). The lowest cell viability/proliferation was found in the highest
concentrations of nanoparticles (0.5 mg/mL) in all the experimental groups (p < 0.001).
The most pronounced and statistically significant increase in cell viability (p < 0.001) was
reported for cells treated with 0.1 mg/mL of nY-ZrO1000 after 24 h of incubation. The
lowest optical density values were recorded in the nY-ZrO800 group at 72 h, suggesting its
mildly toxic behavior. Time dependence and dose dependence were not observed for the
experimental dose and time points, except for cells treated with nY-ZrO1200 after 72 h of
incubation, presenting a statistically significant dose-dependent behavior (p < 0.05).
Figure 5. MTT results of cell viability at different concentrations (0.1, 0.25, 0.5 mg/mL) of yttria stabilized zirconia nanofillers.
** Indicates statistically significant difference (p < 0.001) between treated and untreated cells without nanoparticles (control),
while different letters suggest statistically significant differences (p < 0.001) among concentrations.
3.8. Fluorescence Analysis for the Detection of Reactive Oxygen Species Levels
Figure 6 illustrates that after 24 h of incubation, all specimens showed a statistically
significant reduction of reactive oxygen species as compared to the control (p < 0.001). After
72 h, in nY-ZrO1000 and nY-ZrO1200 specimens, a significant reduction in reactive oxygen
species levels was observed, which was not dependent on NP concentrations (p < 0.01).
Higher antioxidant activity of YSZ800 nanoparticles was observed at the 72h time point in
the concentration of 0.25 mg/mL, indicating its antioxidant properties.
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Figure 6. Reactive oxygen species (ROS) measured using H2DCFDA in HGF cells treated for 24
and 72 h at different concentrations (0.1, 0.25, 0.5 mg/mL) of yttria-stabilized zirconia nanofillers.
* Indicates statistically significant difference (p < 0.05) between treated and untreated cells without
nanoparticles (control), ** indicates statistically significant difference (p < 0.0001) between treated
and untreated cells without nanoparticles, while different letters suggest statistically significant
differences (p < 0.001) among concentrations.
4. Discussion
Because of the favorable properties of zirconia nanoparticles, their synthesis has at-
tracted wide scientific interest over the years, and various methodologies were applied
to optimize their size, crystalline state and morphology, depending on the targeted ap-
plication [7]. ZrO2 and particularly YSZ nanoparticles present high ionic conductivity,
mechanical strength, chemical inertness, high melting point, low thermal conductivity [50]
as well as biocompatibility [51], characteristics that make zirconia nanoparticles attractive
for a wide range of applications. Yttria-stabilized zirconia nanoparticles offer multiple
advantages compared to pure ZrO2 in terms of high mechanical properties, antibacterial
properties and low thermal conductivity that make them attractive candidates for fillers in
dental cement and composite materials [52,53].
In the present study, YSZ nanoparticles were synthesized with the sol–gel technique
based on the Pechini method, as described previously by Hajizadeh-Oghaz [24]. In their
study, spherical tetragonal nanoparticles were synthesized with an average size of 29 nm,
as determined by Scherrer’s formula. This size corresponds to calcination at 1000 ◦C
and is in close agreement with the results of the present study (28.4 nm). Calcination
temperature was found to be the most important factor influencing particle size of YSZ, as
also pointed out in similar studies [24,33,54]. For example, Maridurai et al. [54] synthesized
YSZ nanoparticles by the co-precipitation method and observed an average particle size of
17 nm with TEM analysis and predominantly spherical shape after calcination at 700 ◦C.
Although a different technique was used for the synthesis, Scherrer’s equation indicated
an average size of 12 nm [54], similar to the size of nanoparticles in the present study after
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calcination at 800 ◦C. However, in the study of Maridurai et al. [54], cubic zirconia was the
predominant crystalline phase and not the tetragonal one, as in the present study.
Apart from yttrium, other elements were used to stabilize tetragonal ZrO2 nanoparti-
cles, such as ytterbium (Yb) and gadolinium (Gd) [55]. With these elements, XRD revealed
an increase in size with temperature, as an average size of 19 nm was calculated when
calcination was performed at 600 ◦C and 43 nm following calcination at 1000 ◦C [55]. This
finding was also observed in the present study and is justified by the temperature-induced
grain growth and densification. As shown by SEM micrographs in Figure 3, heating at
1200 ◦C led to significant consolidation of the particles.
Khajavi et al. [56] recently synthesized and evaluated Ce-Y co-doped zirconia nanopar-
ticles by the hydrothermal method, which presented a spherical shape and average size of
8.6 nm after calcination at 900 ◦C. In addition, the authors reported that a predominantly
tetragonal phase of zirconia was detected [56], which is in agreement with the present
study, although their nanoparticles presented a smaller average size. They also emphasized
the significance of retaining the tetragonal phase after heat treatment, which is correlated
to mechanical properties enhancement through the transformation toughening mechanism.
In the present study, the tetragonal phase is well retained at all temperatures, as verified
by the double peaks of the (002)/(200), (113)/(311), (400)/(004) and (402)/(420) planes
in the XRD pattern of the nY-ZrO1000 and TEM analysis of the nY-ZrO1000 [48,49]. The
broadening of the respective peaks in the pattern of the nY-ZrO800 suggests peak over-
lapping [48], which is a common finding, as in X-ray diffraction analysis, the cubic and
tetragonal structures cannot be easily distinguished [48]. A high amount of tetragonal
zirconia and no monoclinic phase were found at 800 ◦C, quite below the phase equilibrium
(1175 ◦C), which can be justified by the nano-scale size of powders that present high surface
area. After the studies of Garvie [57], which suggested that 30 nm of crystalline size is
the critical factor for the stabilization of the tetragonal phase at lower temperatures, many
studies suggested that an even smaller size (18 nm [58] or 10 nm [59]) of zirconia nanocrys-
tals do not inhibit its stabilization, depending on various parameters such as interfacial
energy, strain energy, hydrostatic pressure, water vapor, ion doping, oxygen vacancies,
etc. [60]. Therefore, these critical size factors are strictly applicable only for strain-free ZrO2
nanocrystallites of spherical or near-spherical shape in contact with air at ambient pressure
and temperature. In the present study, the average size calculated by XRD was below 30 nm
at temperatures below 1000 ◦C, which corroborates well with the proposed theories [60].
Similarly, Tailor et al. [34] synthesized YSZ nano-clusters for thermal insulation by the
sol–gel method and, in agreement with our study, mainly detected the tetragonal phase of
YSZ and average particle size of around 40 nm. In the present study, a very small amount
of cubic phase was calculated by the Rietveld method (<5%) for the nYZ-1000, which was
reported in cases of ultrafine crystallites, in the range of 2–20 nm [61,62] and in doped YSZ
nanoparticles [56].
Nanoparticles are prone to spontaneous agglomeration due to high specific surface
area. This surface area is responsible for the lowering of the sintering temperature of
nanoparticles compared to the sintering temperature of their micro-sized counterparts [63].
It was shown that the activation energy for densification of ZrO2 nanoceramics is 50% less
than that of submicron ZrO2 [64]. Stolzenburg et al. [65], using a solvothermal synthesis
method, observed ZrO2 nanoparticles agglomerates of size around 200 nm and justified
their results by a probable instantaneous self-arrangement of nanoparticles after nucle-
ating in the tetragonal phase. In the present study, the respective values were 243.9 nm,
188.96 nm and 364.00 nm, following heating at 800, 1000 and 1200 ◦C, respectively. At high
temperatures, particles draw near and neck-shape junctions between adjacent nanoparticles
permit densification and pore shrinkage, as in the case of nY-ZrO1200. DLS measurements
in the present study suggest a moderate to low polydispersity in all samples, as the poly-
dispersity index (PDI) values are below or around 0.3, but the high average nanoparticle
diameter calculated may be attributed to the tendency of nanoparticles to assemble in
nanoclusters or to the severe distortion of DLS measurements due to nanoparticles poly-
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hedral morphology [66,67]. Considerably larger nanoparticles sizes compared to TEM
and SAXS were recorded by DLS [68], and even slight soft agglomeration or a small
percentage of larger particles can significantly increase the DLS calculated particle size
distribution [66,67].
In order to investigate the biocompatibility and antioxidant activity of the experi-
mentally obtained yttria-zirconia nanoparticles, MTT assay and fluorescence analysis for
detection of ROS levels were performed. Nanoparticles sintered at higher temperatures of
1000 and 1200 ◦C showed biocompatible behavior and thus are not expected to cause any
adverse effects after their addition to luting cement. Nanoparticles sintered at 800 ◦C pre-
sented mildly toxic behavior, probably due to finer particle size as evidenced from the SEM
microphotograph (Figure 3a). Nanoparticles of small size <10 nm can either penetrate the
cell membrane or enter the nucleus, thus being mildly or heavily toxic [69]. Pan et al. [70]
reported that gold NPs of 15 nm in size were 60 times less toxic than 1.4 nm NPs for
fibroblasts, epithelial cells, macrophages and melanoma cells. In agreement with our study,
Zhang et al. [71] reported in vitro cytocompatibility of ZrO2 nanopowders (<50 nm) with
MG-63 cells and L929 fibroblasts in a dose-dependent manner. Cell culture studies with
human umbilical vein endothelial cells (HUVECs) cultured with 500 µg/mL (4.06 mM) of
ZrO2 nanoparticles (30–40 nm) also showed relatively high cell viability (>80%) [72]. In
a study by Rutherford et al. [73], YSZ nanoparticles (approximately 7 nm) with different
molar concentrations of yttria and nano-sized ZrO2 showed biocompatible behavior with
bone marrow mesenchymal stem cells. Even at a high concentration of nanoparticles, cells
maintained their morphology. Further research is needed to elucidate the underlying fac-
tors and mechanisms affecting zirconia nanoparticles’ cytotoxicity at different cell lines. In
general, immediately after nanoparticles’ contact with the biological environment, a certain
layer of proteins will adsorb on their surface, guiding further cells behavior. Applying
shorter time points in the MTT test (i.e., 1, 3 or 6 h) [74] could be an effective strategy to
elucidate the initial effect of these nanoparticles in cell attachment. However, despite the
initial levels of cell attachment, the main effect of nanoparticles on cells’ viability is already
observed at the first 24 h, with a decrease in an increase in cells’ proliferation, but after
48 or 72 h, usually, a balance is acquired if the material is biocompatible. Therefore, we
employed a 3-day MTT test as indicative of the materials’ toxicity, although shorter or
longer evaluation times would be more informative. In addition, further tests are needed
to provide information on the mechanisms of cell damage or death and to explain the
decreased biocompatibility of the nY-ZrO800 observed in this study. Despite the scientific
knowledge related to cell death mechanisms, further work is needed to elucidate the toxico-
logical behavior of the various nanomaterials and to clarify the particular factors that affect
cell fate in their presence. Moreover, there is a need to evaluate if this biological behavior
can affect cell viability when these nanoparticles are used as fillers in dental cement or
adhesives. In this respect, in-depth analysis, as presented in the study of Pagano et al. [74],
and the use of direct cytotoxicity tests on dental cement, adhesives or composites with
nano zirconia nanoparticles fillers should be performed.
The antioxidant potential is an important characteristic of nanoparticles specifying
their free oxygen radical scavenging activity and their ability to protect cells from oxidative
damage. In the current study, all specimens showed a statistically significant reduction
in ROS, indicating the free radical scavenging activity in 24 h, irrespectively of the NPs
concentrations added. It seems that the tested nanofillers were effective in neutralizing
oxidative stress by stabilizing a basal production of ROS. Recently, the pronounced scav-
enging activity of ZrO2–CeO2 nanoparticles attributed to their oxygen storage capacity was
reported by Tsai et al. [75]. Another study found the enhanced antioxidant activity of Fe3O4
stabilized zirconia nanoparticles [76]. At the same time, several studies reported that non-
stabilized ZrO2 nanoparticles could generate ROS and damage the cellular components
as well as the DNA [38,77]. Although a ROS scavenging mechanism due to the presence
of oxygen vacancies in nanomaterials can contribute to those results [78], in the study by
Alzahrani et al. [79], dose-dependent apoptosis and genotoxicity of YSZ nanoparticles in
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human skin keratinocyte cells were correlated with an increase in reactive oxygen species
production at concentrations higher compared with the present study (up to 60 µg/mL),
suggesting that maybe other mechanisms control the overall ROS production and/or scav-
enging. Such diversity in results could probably be attributed to differences in applied
protocols and cell lines, as well as the chemical reactivity of pure zirconia as compared to
its yttria-stabilized form.
Many studies used pure zirconia nanoparticles to enhance the mechanical properties
of dental restorative composites, to enhance the bond strength to dentin of dental cement
and adhesive systems or to increase the radiopacity of dental adhesives (Table 4). A
recent review outlined the beneficial role of the incorporation of nanocompounds in dental
materials with regards to the promotion of their bond’s stability [80].
Table 4. Studies involving zirconia nanoparticles in dental cement, composites and adhesives.
Authors Zirconia NanoparticlesType/Size (nm)
Amount of Filler
(%) w.t. Evaluated Property Main Results
Dental Cements




strength, no release of
Al, Zr or Ti

















Ab Rahman et al. [84] ZrO2 (40 nm)* Glass Ionomer Cement 1, 3, 5, 7, 9, 15, 20 -hardness color
Increased hardness and
aesthetics
Gjorgievska et al. [85] ZrO2 (80 nm)* Glass Ionomer Cement 10 -compressive strength
Increased compressive
strength
















Viapiana et al. [88]
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Table 4. Cont.
Authors Zirconia NanoparticlesType/Size (nm)
Amount of Filler
(%) w.t. Evaluated Property Main Results
Dental Composites




























Dai et al. [30] ZrO2 coated with Zr (OH)4(50 nm) 2.5, 5, 7.5
-flexural strength
-translucency
-5% wt presented the
highest strength











1 wt% led to a
significantly higher
degree of conversion













* = Type of cement in which the nanoparticles were incorporated.
Spherical YSZ nanoparticles of size ranging from 20 to 50 nm were previously pro-
duced by laser vaporization and incorporated in dental adhesives [32]. Zirconia nanoparti-
cle incorporation into the primer or adhesive resin solution of a multi-purpose adhesive
system increased the bond strength significantly to dentin, and even higher strength was
achieved when increased amounts were incorporated into the primer. Martins et al. [95]
incorporated pre-fabricated, commercially available ZrO2 nanoparticles (20–30 nm) in
dental adhesives and found increased radiopacity and micro-hardness.
It was also proposed that ZrO2 nanoparticles can be incorporated in resin-based
composite materials after appropriate silanization [96]. In the study by Kaizer et al. [96],
the average particle size incorporated was 37.3 nm, and it increased to 81.2 nm following
their silica coating. Nanohybrid resin composites with 40 nm zirconia nanoparticles
presented improved and more stable physical properties compared with commercial dental
composites or composites reinforced with nanosilica [97]. In a recent study, zirconia nano-
fillers were incorporated in bis-GMA composite resins [98] up to 5–20 wt%. SEM images
indicated spherical particles with sizes ranging between 20 and 50 nm, and a significant
increase in bending strength was recorded for the composites.
Experimentally reinforced glass ionomer cement has been described in the literature
recently. Gjorgievska et al. [85] attempted the incorporation of ZrO2 nanoparticles of
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average size 80 nm in glass ionomer restorative cement and reported fewer air voids in all
nanoparticle-containing cement, which resulted in fewer cracks within the matrix of the
cement, increasing their strength. Laiteerapong et al. [99] manufactured restorative glass
ionomer cement after incorporation of pre-fabricated zirconia nanoparticles of size under
100nm (ZrO2) and investigated the genotoxicity of their eluates on human gingival fibrob-
lasts. They used nano and micro-sized zirconia particles up to 10% w/w and concluded
that zirconia modified GICs had no genotoxic effect on HGFs in vitro. Sajjad et al. [82]
synthesized nano ZrO2–SiO2–HA, which was incorporated in Fuji IX GIC restorative mate-
rial and detected particles comprising of spherical ZrO2 and SiO2 crystals and rod shape
HA crystals.
Further studies showed that dental materials reinforced with ZrO2 nanoparticles
present cell proliferating and antimicrobial properties. Specifically, Silva et al. [100] used
ZrO2 nanoparticles to reinforce a calcium silicate-based cement and observed an increase
in fibroblast proliferation and reduced duration of the inflammatory response by rat
fibroblasts. In the study by Bosso-Martelo et al. [101], 74 nm-sized ZrO2 were incorpo-
rated into calcium silicate-based cement, resulting in bioactive materials, as evidenced
by the hydroxyapatite precipitates on the surface of the specimens. In restorative glass
ionomer cement, relative biocompatibility to human gingival fibroblasts was reported by
Laiteerapong et al. [99]. Antimicrobial effects against microorganisms found in the oral
cavity, particularly against Gram-negative bacteria, were reported by Fathima et al. [12]. In
their study, particles synthesized by a method involving precipitation presented irregular
spherical or spherical shapes, and their size ranged between 15 and 21 nm. The findings
above indicate that the applied synthesis method in the present study led to smaller YSZ
particle sizes (10–15 nm and 30–50 nm, respectively, for sintering temperatures of 800 ◦C
and 1000 ◦C) when comparing them to the ZrO2 nanoparticles used in most studies.
It can be assumed that the favorable biological properties and crystallographic char-
acteristics observed in the present study could allow applications of these nanoparticles
in dental materials that require strict working times, viscosity and film thickness, such as
luting cement. Other applications could include restorative materials as well as dental
adhesives and root-end filling materials. The existing evidence on their biological and
mechanical properties is promising with regards to their use as optimized fillers. However,
this study has some limitations. A more detailed analysis should be performed in terms
of explaining the underlying mechanisms of cells response and the differences depend-
ing on the sintering temperature. A more detailed TEM analysis on the nY-ZrO800 and
nY-ZrO1200 should provide clarifying information on the role of any particular structural
and morphological characteristics of nanoparticles on their biological response and ROS
production to allow optimization of their production. Their biocompatibility should also
be evaluated in comparison with pure ZrO2 nanoparticles to elucidate any potential effect
of yttrium in their composition. Future studies in light of the above and the use of other
cell lines such as dental pulp stem cells should be considered for conclusive results.
In the present study, yttrium stabilized zirconia nanoparticles were synthesized
through a sol–gel-based method, and their biocompatibility were evaluated after sin-
tering at various temperatures. As a different biological behavior was observed depending
on sintering temperature, the null hypothesis was rejected.
5. Conclusions
Pure tetragonal YSZ nanopowders with low agglomeration were successfully syn-
thesized by the sol–gel method at different temperatures. The size and crystallographic
characteristics of the synthesized nanoparticles suggest the heat treatment at temperatures
≤1000 ◦C can lead to optimum properties, making YSZ nanoparticles potentially suitable
as nanofillers for resin luting cement in dentistry. The results of the present study suggest
that the sol–gel method is an effective alternative to traditional high-temperature synthesis
techniques for the stabilization of the tetragonal zirconia at room temperature and the
elimination of any monoclinic traces.
Dent. J. 2021, 9, 128 15 of 19
Author Contributions: Conceptualization, A.E.R. and E.K.; methodology, A.B., A.T. and I.T.; valida-
tion, E.-G.C.T.; formal analysis, G.K.P., L.L., D.K., M.A.O., A.A. and I.T.; investigation, A.B., G.K.P.,
E.-G.C.T., A.A. and I.T.; data curation, E.K.; writing—original draft preparation, A.B., A.E.R. and I.T.;
writing—review and editing, E.K.; visualization, G.K.P., L.L. and D.K.; supervision, E.K. and I.G.T.;
project administration, E.K. and I.G.T.; funding acquisition, E.K. All authors have read and agreed to
the published version of the manuscript.
Funding: This research was co-financed by Greece and European Union (EUROPEAN SOCIAL
FUND-ESF), through the Operational Program “Human Resources Development, Education, and
Lifelong Learning 2014–2020” in the context of the project “Development of zirconia adhesion cements
with stabilized zirconia nanoparticles: physicochemical properties and bond strength under aging
conditions” grant number MIS5047876.
Institutional Review Board Statement: The study was conducted according to the guidelines of the
Declaration of Helsinki and approved by the Ethics Committee of the School of Dentistry, Aristotle
University of Thessaloniki, Greece (#35/07-05-2018).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: Data is contained within the article.
Acknowledgments: The authors would like to acknowledge Konstantinos Simeonidis for XRD anal-
ysis and Triantafillia Zorba for assistance in FTIR analysis. The authors want to thank Konstantinos
Chrysafis for providing the facilities of the Laboratory of Advanced Materials and Devices at Aristotle
University of Thessaloniki (http://amdelab.physics.auth.gr/members-en.htm, 27 October 2021). The
authors thank Aldo R. Boccaccini for granting access to the facilities (SEM-EDX and DLS analyses)
at the Institute of Biomaterials, Department of Materials Science and Engineering, University of
Erlangen-Nuremberg.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Gautam, C.; Joyner, J.; Gautam, A.; Rao, J.; Vajtai, R. Zirconia based dental ceramics: Structure, mechanical properties, biocompat-
ibility and applications. Dalt. Trans. 2016, 45, 19194–19215. [CrossRef] [PubMed]
2. Vagkopoulou, T.; Koutayas, S.O.; Koidis, P.; Strub, J.R. Zirconia in dentistry: Part 1. Discovering the nature of an upcoming
bioceramic. Eur. J. Esthet. Dent. 2009, 4, 130–151. [PubMed]
3. Koutayas, S.O.; Vagkopoulou, T.; Pelekanos, S.; Koidis, P.; Strub, J.R. Zirconia in dentistry: Part 2. Evidence-based clinical
breakthrough. Eur. J. Esthet. Dent. 2009, 4, 348–380. [PubMed]
4. Habib, E.; Wang, R.; Wang, Y.; Zhu, M.; Zhu, X.X. Inorganic Fillers for Dental Resin Composites: Present and Future. ACS Biomater.
Sci. Eng. 2016, 2, 1–11. [CrossRef]
5. Wang, T.; Tsoi, J.K.H.; Matinlinna, J.P. A novel zirconia fibre-reinforced resin composite for dental use. J. Mech. Behav. Biomed.
Mater. 2016, 53, 151–160. [CrossRef]
6. Das, I.; Chattopadhyay, S.; Mahato, A.; Kundu, B.; De, G. Fabrication of a cubic zirconia nanocoating on a titanium dental implant
with excellent adhesion, hardness and biocompatibility. RSC Adv. 2016, 6, 59030–59038. [CrossRef]
7. Hu, C.; Sun, J.; Long, C.; Wu, L.; Zhou, C.; Zhang, X. Synthesis of nano zirconium oxide and its application in dentistry.
Nanotechnol. Rev. 2019, 8, 396–404. [CrossRef]
8. Guerreiro Tanomaru, J.M.; Storto, I.; da Silva, G.F.; Bosso, R.; Costa, B.C.; Bernardi, M.I.B.; Tanomaru-Filho, M. Radiopacity, pH
and antimicrobial activity of Portland cement associated with micro- and nanoparticles of zirconium oxide and niobium oxide.
Dent. Mater. J. 2014, 33, 466–470. [CrossRef]
9. Bortoluzzi, E.A.; Guerreiro-Tanomaru, J.M.; Tanomaru-Filho, M.; Duarte, M.A.H. Radiographic effect of different radiopacifiers on
a potential retrograde filling material. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology 2009, 108, 628–632. [CrossRef]
10. Gad, M.M.; Rahoma, A.; Al-Thobity, A.M.; ArRejaie, A.S. Influence of incorporation of ZrO2 nanoparticles on the repair strength
of polymethyl methacrylate denture bases. Int. J. Nanomed. 2016, 11, 5633–5643. [CrossRef]
11. Yang, J.; Shen, J.; Wu, X.; He, F.; Xie, H.; Chen, C. Effects of nano-zirconia fillers conditioned with phosphate ester monomers on
the conversion and mechanical properties of Bis-GMA- and UDMA-based resin composites. J. Dent. 2020, 94, 103306. [CrossRef]
Dent. J. 2021, 9, 128 16 of 19
12. Fathima, J.B.; Pugazhendhi, A.; Venis, R. Synthesis and characterization of ZrO2 nanoparticles-antimicrobial activity and their
prospective role in dental care. Microb. Pathog. 2017, 110, 245–251. [CrossRef]
13. Souza, J.C.M.; Silva, J.B.; Aladim, A.; Carvalho, O.; Nascimento, R.M.; Silva, F.S.; Martinelli, A.E.; Henriques, B. Effect of Zirconia
and Alumina Fillers on the Microstructure and Mechanical Strength of Dental Glass Ionomer Cements. Open Dent. J. 2016, 10,
58–68. [CrossRef]
14. Lyon, D.; Chevalier, J.; Gremillard, L.; Cam, C.a.D. Zirconia as a Biomaterial. Compr. Biomater. 2011, 20, 95–108. [CrossRef]
15. Chevalier, J. What future for zirconia as a biomaterial? Biomaterials 2006, 27, 535–543. [CrossRef]
16. Chevalier, J.J.; Gremillard, L.; Virkar, A.V.; Clarke, D.R. The tetragonal-monoclinic transformation in zirconia: Lessons learned
and future trends. J. Am. Ceram. Soc. 2009, 92, 1901–1920. [CrossRef]
17. Piconi, C.; Maccauro, G. Zirconia as a ceramic biomaterial. Biomaterials 1999, 20, 1–25. [CrossRef]
18. Chevalier, J.; Gremillard, L.; Deville, S. Low-Temperature Degradation of Zirconia and Implications for Biomedical Implants.
Annu. Rev. Mater. Res. 2007, 37, 1–32. [CrossRef]
19. Sheu, T.-S.; Tien, T.-Y.; Chen, I.-W. Cubic-to-Tetragonal (t’) Transformation in Zirconia-Containing Systems. J. Am. Ceram. Soc.
1992, 75, 1108–1116. [CrossRef]
20. Bona, A.D.; Pecho, O.E.; Alessandretti, R. Zirconia as a Dental Biomaterial. Materials 2015, 8, 4978–4991. [CrossRef]
21. Kontonasaki, E.; Giasimakopoulos, P.; Rigos, A.E. Strength and aging resistance of monolithic zirconia: An update to current
knowledge. Jpn. Dent. Sci. Rev. 2020, 56, 1–23. [CrossRef]
22. Vasylkiv, O.; Sakka, Y. Synthesis and colloidal processing of zirconia nanopowder. J. Am. Ceram. Soc. 2001, 84, 2489–2494.
[CrossRef]
23. Tok, A.I.Y.; Boey, F.Y.C.; Du, S.W.; Wong, B.K. Flame spray synthesis of ZrO2 nano-particles using liquid precursors. Mater. Sci.
Eng. B Solid-State Mater. Adv. Technol. 2006, 130, 114–119. [CrossRef]
24. Hajizadeh-Oghaz, M.; Razavi, R.S.; Estarki, M.L. Large-scale synthesis of YSZ nanopowder by Pechini method. Bull. Mater. Sci.
2014, 37, 969–973. [CrossRef]
25. Sagadevan, S.; Podder, J.; Das, I. Hydrothermal synthesis of zirconium oxide nanoparticles and its characterization. J. Mater. Sci.
Mater. Electron. 2016, 27, 5622–5627. [CrossRef]
26. Heshmatpour, F.; Khodaiy, Z.; Aghakhanpour, R.B. Synthesis and characterization of pure tetragonal nanocrystalline sulfated
8YSZ powder by sol-gel route. Powder Technol. 2012, 224, 12–18. [CrossRef]
27. Hsu, Y.W.; Yang, K.H.; Chang, K.M.; Yeh, S.W.; Wang, M.C. Synthesis and crystallization behavior of 3 mol% yttria stabilized
tetragonal zirconia polycrystals (3Y-TZP) nanosized powders prepared using a simple co-precipitation process. J. Alloys Compd.
2011, 509, 6864–6870. [CrossRef]
28. Sato, K.; Horiguchi, K.; Nishikawa, T.; Yagishita, S.; Kuruma, K.; Murakami, T.; Abe, H. Hydrothermal Synthesis of Yttria-
Stabilized Zirconia Nanocrystals with Controlled Yttria Content. Inorg. Chem. 2015, 54, 7976–7984. [CrossRef]
29. Gonzalo-Juan, I.; Ferrari, B.; Colomer, M.T. Influence of the urea content on the YSZ hydrothermal synthesis under dilute
conditions and its role as dispersant agent in the post-reaction medium. J. Eur. Ceram. Soc. 2009, 29, 3185–3195. [CrossRef]
30. Dai, S.; Chen, Y.; Yang, J.; He, F.; Chen, C.; Xie, H. Surface treatment of nanozirconia fillers to strengthen dental bisphenol
a–glycidyl methacrylate–based resin composites. Int. J. Nanomed. 2019, 14, 9185–9197. [CrossRef]
31. Alhareb, A.O.; Akil, H.M.; Ahmad, Z.A. Impact strength, fracture toughness and hardness improvement of PMMA denture base
through addition of nitrile rubber/ceramic fillers. Saudi. J. Dent. Res. 2017, 8, 26–34. [CrossRef]
32. Lohbauer, U.; Wagner, A.; Belli, R.; Stoetzel, C.; Hilpert, A.; Kurland, H.D.; Grabow, J.; Müller, F.A. Zirconia nanoparticles
prepared by laser vaporization as fillers for dental adhesives. Acta Biomater. 2010, 6, 4539–4546. [CrossRef] [PubMed]
33. Hajizadeh-Oghaz, M.; Shoja Razavi, R.; Loghman-Estarki, M.R. Synthesis and characterization of non-transformable tetragonal
YSZ nanopowder by means of Pechini method for thermal barrier coatings (TBCs) applications. J. Sol.-Gel Sci. Technol. 2014, 70,
6–13. [CrossRef]
34. Tailor, S.; Singh, M.; Doub, A.V. Synthesis and Characterization of Yttria-Stabilized Zirconia (YSZ) Nano-Clusters for Thermal
Barrier Coatings (TBCs) Applications. J. Clust. Sci. 2016, 27, 1097–1107. [CrossRef]
35. Aly, K.A.; Khalil, N.M.; Algamal, Y.; Saleem, Q.M.A. Estimation of lattice strain for zirconia nano-particles based on Williamson-
Hall analysis. Mater. Chem. Phys. 2017, 193, 182–188. [CrossRef]
36. Wu, X.; Landheer, D.; Graham, M.J.; Chen, H.W.; Huang, T.Y.; Chao, T.S. Structure and thermal stability of MOCVD ZrO2 films
on Si (1 0 0). J. Cryst. Growth 2003, 250, 479–485. [CrossRef]
37. Karunakaran, G.; Suriyaprabha, R.; Manivasakan, P.; Yuvakkumar, R.; Rajendran, V.; Kannan, N. Screening of in vitro cytotoxicity,
antioxidant potential and bioactivity of nano- and micro-ZrO2 and -TiO2 particles. Ecotoxicol. Environ. Saf. 2013, 93, 191–197.
[CrossRef]
38. Asadpour, E.; Sadeghnia, H.R.; Ghorbani, A.; Sedaghat, M.; Boroushaki, M.T. Oxidative stress-mediated cytotoxicity of zirconia
nanoparticles on PC12 and N2a cells. J. Nanoparticle Res. 2016, 18, 1–13. [CrossRef]
39. Avalos, A.; Haza, A.I.; Mateo, D.; Morales, P. Interactions of manufactured silver nanoparticles of different sizes with normal
human dermal fibroblasts. Int. Wound J. 2016, 13, 101–109. [CrossRef]
40. Tsamesidis, I.; Reybier, K.; Marchetti, G.; Pau, M.C.; Virdis, P.; Fozza, C.; Nepveu, F.; Low, P.S.; Turrini, F.M.; Pantaleo, A. Syk
kinase inhibitors synergize with artemisinins by enhancing oxidative stress in plasmodium falciparum-parasitized erythrocytes.
Antioxidants 2020, 9, 753. [CrossRef]
Dent. J. 2021, 9, 128 17 of 19
41. Halmenschlager, C.M.; Vieira, R.; Falcade, T. Characterization of Cubic Yttria-Stabilized. In Proceedings of the International
Latin-American Conference on Powder Technology, Atibaia, Brazil, 8–10 November 2009; pp. 890–895.
42. Courtin, E.; Boy, P.; Rouhet, C.; Bianchi, L.; Bruneton, E.; Poirot, N.; Laberty-Robert, C.; Sanchez, C. Optimized Sol-Gel Routes to
Synthesize Yttria- Stabilized Zirconia Thin Films as Solid Electrolytes for Solid Oxide Fuel Cells. Chem. Mater. 2012, 24, 4540–4548.
[CrossRef]
43. Judes, J.; Kamaraj, V. Preparation and characterization of yttria stabilized zirconia minispheres by the sol-gel drop generation
method. Mater. Sci. Pol. 2009, 27, 407–415.
44. Zarkov, A.; Stanulis, A.; Sakaliuniene, J.; Butkute, S.; Abakeviciene, B.; Salkus, T.; Tautkus, S.; Orliukas, A.F.; Tamulevicius,
S.; Kareiva, A. On the synthesis of yttria-stabilized zirconia: A comparative study. J. Sol.-Gel Sci. Technol. 2015, 76, 309–319.
[CrossRef]
45. Huang, Z.; Han, W.; Feng, Z.; Qi, J.; Wu, D.; Wei, N.; Tang, Z.; Zhang, Y.; Duan, J.; Lu, T. The effects of precipitants on co-
precipitation synthesis of yttria-stabilized zirconia nanocrystalline powders. J. Sol-Gel Sci. Technol. 2019, 90, 359–368. [CrossRef]
46. Fernandez Lopez, E.; Sanchez Escribano, V.; Panizza, M.; Carnasciali, M.M.; Busca, G. Vibrational and electronic spectroscopic
properties of zirconia powders. J. Mater. Chem. 2001, 11, 1891–1897. [CrossRef]
47. Niu, X.; Xie, M.; Zhou, F.; Mu, R.; Song, X.; An, S. Substituent influence of yttria by gadolinia on the tetragonal phase stability for
Y2O3-Ta2O5-ZrO2 ceramics at 1300 ◦C. J. Mater. Sci. Technol. 2014, 30, 381–386. [CrossRef]
48. Srinivasan, R.; De Angelis, R.J.; Ice, G.; Davis, B.H. Identification of tetragonal and cubic structures of zirconia using synchrotron
x-radiation source. J. Mater. Res. 1991, 6, 1287–1292. [CrossRef]
49. Zhang, F.; Reveron, H.; Spies, B.C.; Van Meerbeek, B.; Chevalier, J. Trade-off between fracture resistance and translucency of
zirconia and lithium-disilicate glass ceramics for monolithic restorations. Acta Biomater. 2019, 91, 24–34. [CrossRef]
50. Kumari, L.; Li, W.Z.; Xu, J.M.; Leblanc, R.M.; Wang, D.Z.; Li, Y.; Guo, H.; Zhang, J. Controlled hydrothermal synthesis of
zirconium oxide nanostructures and their optical properties. Cryst. Growth Des. 2009, 9, 3874–3880. [CrossRef]
51. Zong, S.; Cao, Y.; Zhou, Y.; Ju, H. Zirconia nanoparticles enhanced grafted collagen tri-helix scaffold for unmediated biosensing of
hydrogen peroxide. Langmuir 2006, 22, 8915–8919. [CrossRef]
52. Pérez-Tanoira, R.; Horwat, D.; Kinnari, T.J.; Pérez-Jorge, C.; Gómez-Barrena, E.; Migot, S.; Esteban, J. Bacterial adhesion on
biomedical surfaces covered by yttria stabilized zirconia. J. Mater. Sci. Mater. Med. 2016, 27, 1–9. [CrossRef] [PubMed]
53. Lahwal, A.; Bhattacharya, S.; He, J.; Wu, D.; Peterson, A.; Poon, S.J.; Williams, L.; Dehkordi, A.M.; Tritt, T.M. Impact of yttria
stabilized zirconia nanoinclusions on the thermal conductivity of n-type Si80 Ge20 alloys prepared by spark plasma sintering. J.
Appl. Phys. 2015, 117, 145101. [CrossRef]
54. Maridurai, T.; Balaji, D.; Sagadevan, S. Synthesis and Characterization of Yttrium Stabilized Zirconia Nanoparticles. Mater. Res.
2016, 19, 812–816. [CrossRef]
55. Bahamirian, M.; Hadavi, S.M.M.; Rahimipour, M.R.; Farvizi, M.; Keyvani, A. Synthesis and Characterization of Yttria-Stabilized
Zirconia Nanoparticles Doped with Ytterbium and Gadolinium: ZrO2 9.5Y2O3 5.6Yb2O3 5.2Gd2O3. Metall. Mater. Trans. A Phys.
Metall. Mater. Sci. 2018, 49, 2523–2532. [CrossRef]
56. Khajavi, P.; Xu, Y.; Frandsen, H.L.; Chevalier, J.; Gremillard, L.; Kiebach, R.; Hendriksen, P.V. Tetragonal phase stability maps of
ceria-yttria co-doped zirconia: From powders to sintered ceramics. Ceram. Int. 2020, 46, 9396–9405. [CrossRef]
57. Garvie, R.C. The occurrence of metastable tetragonal zirconia as a crystallite size effect. J. Phys. Chem. 1965, 69, 1238–1243.
[CrossRef]
58. Chraska, T.; King, A.H.; Berndt, C.C. On the size-dependent phase transformation in nanoparticulate zirconia. Mater. Sci. Eng. A
2000, 286, 169–178. [CrossRef]
59. Nitsche, R.; Winterer, M.; Hahn, H. Structure of nanocrystalline zirvonia and yttria. Nanostructured Mater. 1995, 6, 679–682.
[CrossRef]
60. Shukla, S.; Seal, S. Mechanisms of room temperature metastable tetragonal phase stabilisation in zirconia. Int. Mater. Rev. 2005,
50, 45–64. [CrossRef]
61. Tsunekawa, S.; Ito, S.; Kawazoe, Y.; Wang, J.T. Critical size of the phase transition from cubic to tetragonal in pure zirconia
nanoparticles. Nano Lett. 2003, 3, 871–875. [CrossRef]
62. Chatterjee, A.; Pradhan, S.K.; Datta, A.; De, M.; Chakravorty, D. Stability of Cubic Phase in Nanocrystalline ZrO2. J. Mater. Res.
1994, 9, 263–265. [CrossRef]
63. Lu, K. Sintering of nanoceramics. Int. Mater. Rev. 2008, 53, 21–38. [CrossRef]
64. Maca, K.; Trunec, M.; Dobsak, P. Bulk zirconia nanoceramics prepared by cold isostatic pressing and pressureless sintering. Rev.
Adv. Mater. Sci. 2005, 10, 84–88.
65. Stolzenburg, P.; Hämisch, B.; Richter, S.; Huber, K.; Garnweitner, G. Secondary Particle Formation during the Nonaqueous
Synthesis of Metal Oxide Nanocrystals. Langmuir 2018, 34, 12834–12844. [CrossRef]
66. Tobler, D.J.; Shaw, S.; Benning, L.G. Quantification of initial steps of nucleation and growth of silica nanoparticles: An in-situ
SAXS and DLS study. Geochim. Cosmochim. Acta 2009, 73, 5377–5393. [CrossRef]
67. Tomaszewska, E.; Soliwoda, K.; Kadziola, K.; Tkacz-Szczesna, B.; Celichowski, G.; Cichomski, M.; Szmaja, W.; Grobelny, J.
Detection limits of DLS and UV-Vis spectroscopy in characterization of polydisperse nanoparticles colloids. J. Nanomater. 2013,
2013, 60. [CrossRef]
Dent. J. 2021, 9, 128 18 of 19
68. Pabisch, S.; Feichtenschlager, B.; Kickelbick, G.; Peterlik, H. Effect of interparticle interactions on size determination of zirconia
and silica based systems—A comparison of SAXS, DLS, BET, XRD and TEM. Chem. Phys. Lett. 2012, 521, 91–97. [CrossRef]
69. Sukhanova, A.; Bozrova, S.; Sokolov, P.; Berestovoy, M.; Karaulov, A.; Nabiev, I. Dependence of Nanoparticle Toxicity on Their
Physical and Chemical Properties. Nanoscale Res. Lett. 2018, 13, 44. [CrossRef]
70. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent
cytotoxicity of gold nanoparticles. Small 2007, 3, 1941–1949. [CrossRef]
71. Zhang, Y.F.; Zheng, Y.F.; Qin, L. A comprehensive biological evaluation of ceramic nanoparticles as wear debris. Nanomed.
Nanotechnol. Biol. Med. 2011, 7, 975–982. [CrossRef]
72. Wang, J.; Yin, W.; He, X.; Wang, Q.; Guo, M.; Chen, S. Good Biocompatibility and Sintering Properties of Zirconia Nanoparticles
Synthesized via Vapor-phase Hydrolysis. Sci. Rep. 2016, 6, 35020. [CrossRef] [PubMed]
73. Rutherford, D.; Exarhos, S.; Xu, C.; Niacaris, M.; Mariano, C.; Dayap, B.; Mangolini, L.; Liu, H. Synthesis, characterization, and
cytocompatibility of yttria stabilized zirconia nanopowders for creating a window to the brain. J. Biomed. Mater. Res. Part. B Appl.
Biomater. 2020, 108, 925–938. [CrossRef] [PubMed]
74. Pagano, S.; Lombardo, G.; Costanzi, E.; Balloni, S.; Bruscoli, S.; Flamini, S.; Coniglio, M.; Valenti, C.; Cianetti, S.; Marinucci, L.
Morpho-functional effects of different universal dental adhesives on human gingival fibroblasts: An in vitro study. Odontology
2021, 109, 524–539. [CrossRef] [PubMed]
75. Tsai, Y.Y.; Oca-Cossio, J.; Lin, S.M.; Woan, K.; Yu, P.C.; Sigmund, W. Reactive oxygen species scavenging properties of ZrO2-CeO2
solid solution nanoparticles. Nanomedicine 2008, 3, 637–645. [CrossRef]
76. Imran, M.; Riaz, S.; Shah, S.M.H.; Batool, T.; Khan, H.N.; Sabri, A.N.; Naseem, S. In-vitro hemolytic activity and free radical
scavenging by sol-gel synthesized Fe3O4 stabilized ZrO2 nanoparticles. Arab. J. Chem. 2020, 13, 7598–7608. [CrossRef]
77. Atalay, H.; Çelík, A.; Ayaz, F. Investigation of genotoxic and apoptotic effects of zirconium oxide nanoparticles (20 nm) on L929
mouse fibroblast cell line. Chem. Biol. Interact. 2018, 296, 98–104. [CrossRef]
78. Gunawan, C.; Lord, M.S.; Lovell, E.; Wong, R.J.; Jung, M.S.; Oscar, D.; Mann, R.; Amal, R. Oxygen-Vacancy Engineering of
Cerium-Oxide Nanoparticles for Antioxidant Activity. ACS Omega 2019, 4, 9473–9479. [CrossRef]
79. Alzahrani, F.M.; Katubi, K.M.S.; Ali, D.; Alarifi, S. Apoptotic and DNA-damaging effects of yttriastabilized zirconia nanoparticles
on human skin epithelial cells. Int. J. Nanomed. 2019, 14, 7003–7016. [CrossRef]
80. Münchow, E.A.; Bottino, M.C. Recent Advances in Adhesive Bonding: The Role of Biomolecules, Nanocompounds, and Bonding
Strategies in Enhancing Resin Bonding to Dental Substrates. Curr. Oral Heal. Rep. 2017, 4, 215–227. [CrossRef]
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